NSPR — InspireMD Cashflow Statement
0.000.00%
Last trade - 00:00- $62.21m
- $28.26m
- $6.21m
- 33
- 15
- 67
- 32
Annual cashflow statement for InspireMD, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10 | -10.5 | -14.9 | -18.5 | -19.9 |
| Depreciation | |||||
| Non-Cash Items | 0.5 | 0.835 | 1.61 | 2.37 | 4.11 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.428 | 0.477 | -0.061 | 0.395 | -0.801 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -9.81 | -9.08 | -13.2 | -15.5 | -16.4 |
| Capital Expenditures | -0.284 | -0.088 | -0.344 | -0.473 | -0.381 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.103 | -0.099 | -22.1 | 8.91 | -15.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.387 | -0.187 | -22.5 | 8.44 | -16.1 |
| Financing Cash Flow Items | — | — | — | -0.14 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 6.33 | 16.4 | 35 | -0.14 | 37.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.87 | 7.13 | -0.641 | -7.37 | 5.01 |